Bicycle Therapeutics plc (BCYC) Misses Q1 EPS by 22c

Bicycle Therapeutics plc (NASDAQ: BCYC) reported Q1 EPS of ($1.30), $0.22 worse than the analyst estimate of ($1.08). Revenue for the quarter came in at $4.9 million versus the consensus estimate of $3.87 million.

For earnings history and earnings-related data on Bicycle Therapeutics plc (BCYC) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c
• Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c